Third Trademark Issued
(BUFFALO, NY) Apr. 1, 2022—Efferent Labs, Inc., a preclinical-stage biodevice company focused on in vivo cellular data, today announced that the United States Patent and Trademark Office (USPTO) issued U.S. Trademark No. 6,687.149…